More about

Glucocorticoid

News
July 17, 2020
3 min read
Save

Certain drugs may promote unintentional weight gain in postmenopausal women

Certain drugs may promote unintentional weight gain in postmenopausal women

Postmenopausal women who are prescribed antidepressants, beta-blockers and insulin are more likely to experience weight gain than those who do not use these medications, according to a study published in Menopause.

News
June 18, 2020
4 min read
Save

Steroid use increases COVID-19 hospitalization risk for patients with rheumatic diseases

Steroid use increases COVID-19 hospitalization risk for patients with rheumatic diseases

Moderate to high glucocorticoid use, defined as 10 mg per day or more, is associated with a greater risk for hospitalization for COVID-19 among patients with rheumatic disease, according to data published in Annals of the Rheumatic Diseases.

News
June 09, 2020
3 min read
Save

Nonsteroidal treatment reduces androgen levels in congenital adrenal hyperplasia

Nonsteroidal treatment reduces androgen levels in congenital adrenal hyperplasia

Adults with congenital adrenal hyperplasia who received an oral corticotropin-releasing hormone antagonist for 14 days experienced significant reductions in androgen levels with no serious adverse events, study data show.

News
April 22, 2020
3 min read
Save

Ruxolitinib effective, safe for glucocorticoid-refractory acute GVHD

Ruxolitinib effective, safe for glucocorticoid-refractory acute GVHD

Ruxolitinib appeared to be more effective than common treatments for patients with glucocorticoid-refractory acute graft-versus-host-disease, according to results of a randomized phase 3 study published in The New England Journal of Medicine.

News
April 16, 2020
4 min read
Save

Physical therapy superior to glucocorticoid injection for OA pain, functional disability

Physical therapy superior to glucocorticoid injection for OA pain, functional disability

Patients with knee osteoarthritis who participated in physical therapy demonstrated less pain and functional disability at 1 year compared with those who received glucocorticoid injection, according to data published in The New England Journal of Medicine.

News
April 02, 2020
3 min read
Save

Endocrinologists warn of increased COVID-19 complication risks with glucocorticoid use

Endocrinologists warn of increased COVID-19 complication risks with glucocorticoid use

Adults who are prescribed glucocorticoid therapy for common conditions, such as asthma, allergies and arthritis, as well as individuals with adrenal insufficiency, are at high risk for developing serious complications from COVID-19 due to an inability to mount a normal stress response, according to an editorial published in the Journal of Clinical Endocrinology & Metabolism.

News
April 01, 2020
2 min read
Save

Study further characterizes critical illness in COVID-19

Study further characterizes critical illness in COVID-19

A new study published in The New England Journal of Medicine has offered further characterization of critically ill patients with COVID-19 who received treatment in the Seattle region.

News
February 26, 2020
4 min read
Save

Metabolic effects of glucocorticoids reversed with metformin

Metabolic effects of glucocorticoids reversed with metformin

Adults with inflammatory disease prescribed glucocorticoid therapy experienced an improvement in several metabolic parameters after adding metformin therapy for 12 weeks compared with similar adults assigned placebo, according to findings from a phase 2 study published in The Lancet Diabetes & Endocrinology.

News
January 26, 2020
1 min read
Save

Top recent neuroendocrinology and adrenal news

Endocrine Today has compiled a list of the top recent news reports focused on neuroendocrinology and adrenal medicine.

News
January 17, 2020
2 min read
Save

Early glucocorticoid treatment in congenital adrenal hyperplasia may boost cognitive function

Early glucocorticoid treatment in congenital adrenal hyperplasia may boost cognitive function

Children and adolescents with congenital adrenal hyperplasia, or CAH, diagnosed early via a neonatal screening program and treated with hydrocortisone had normal psychometric intelligence and executive function compared with population controls, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

View more